Company / Current Liabilities per Share
LENZ Therapeutics, Inc. Current Liabilities per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.77
FY2025
5-year range
$0.24 / $9.45
FY2021-FY2025
Trend
+57.5%
vs FY2024
Sector context
#127 of 210
Health Care
What the data says
At $0.77, LENZ Therapeutics, Inc.'s current liabilities per share ranks #84 of 210 in the Health Care sector. Current Liabilities per Share has fluctuated over the past 6 years, ranging from $0.24 in FY2022 to $14.03 in FY2020.
Based on SEC 10-K filings.
0.77 in FY2025 with a 5-year CAGR of -44.0%.
Improved from $9.45 to $0.77 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +48.0%
- 5-Year CAGR
- -44.0%
- 10-Year CAGR
- -
Sector benchmark
#84 of 210 in Health CareTop 40% of 210This company $0.77 Sector average $23.79
▼
-96.8% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 57.5% year-over-year.
- Ranks #127 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2020.
- Lowest current liabilities per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.71 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.77 | +57.5% |
| FY2024 | $0.49 | -94.8% |
| FY2023 | $9.45 | +3875.9% |
| FY2022 | $0.24 | -43.4% |
| FY2021 | $0.42 | -97.0% |
| FY2020 | $14.03 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026